Micreos Pharmaceuticals AG
History from 14 Dec 2021
- UID
- CHE-430.397.336
- Legal form
- AG
- Canton
- ZG
- Founded
- 14 Dec 2021
- Amount raised
- not in the SHAB
- Lead investor
- not in the SHAB
- shares
- Vorzugsaktien Class B1
- Vorzugsaktien Class B2
Record
SHAB published 17 Dec 2021 · legal date 14 Dec 2021
Company formed
Founded 14 Dec 2021
SHAB HR01-1005360089 ↗SHAB published 6 Oct 2025 · legal date 23 Sep 2025
Capital increase
Capital increasedPaid by converting claims
- Nominal capital
- 200’000 → 399’999.69
- Shares
- 20’000’000 → 39’999’969
- New shares, % of post-step shares
- 50.0% (19’999’969 new)
Aktienkapital neu: CHF 399'999.69 [bisher: CHF 200'000.00]. Liberierung Aktienkapital neu: CHF 399'999.69 [bisher: CHF 200'000.00]. Aktien neu: 39'999'969 vinkulierte Namenaktien zu CHF 0.01 [bisher: 20'000'000 vinkulierte Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗ SHAB HR02-1006450194 ↗Classifier score 0.22 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 12 Feb 2026 · legal date 4 Feb 2026
Capital increase
Likely financingPaid in cash and by other means
- Nominal capital
- 399’999.69 → 475’045.68
- Shares
- 39’999’969 → 47’504’568
- New shares, % of post-step shares
- 15.8% (7’504’599 new)
- Share classes
- 39’999’969 × CHF 0.01 · 6’614’771 × CHF 0.01 Vorzugsaktien Class B1 · 889’828 × CHF 0.01 Vorzugsaktien Class B2
Aktienkapital neu: CHF 475'045.68 [bisher: CHF 399'999.69]. Liberierung Aktienkapital neu: CHF 475'045.68 [bisher: CHF 399'999.69]. Aktien neu: 39'999'969 vinkulierte Namenaktien zu CHF 0.01, 6'614'771 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B1) und 889'828 Namenaktien zu CHF 0.01 (Vorzugsaktien Class B2) [bisher: 39'999'969 vinkulierte Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung. Kapitalband gemäss näherer Umschreibung in den Statuten.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗ SHAB HR02-1006567792 ↗Classifier score 0.88 · likely-financing threshold 0.60 · not a calibrated probability
SHAB published 12 Feb 2026 · legal date 4 Feb 2026
Capital band adopted
SHAB HR02-1006567792 ↗SHAB published 5 Aug 2026 · legal date 27 Jul 2026
Capital increase
Likely financingPaid in cash and by other means
- Nominal capital
- 475’045.68 → 518’497.64
- Shares
- 47’504’568 → 51’849’764
- New shares, % of post-step shares
- 8.4% (4’345’196 new)
- Share classes
- 39’999’969 × CHF 0.01 · 9’180’309 × CHF 0.01 Vorzugsaktien Class B1 · 2’669’486 × CHF 0.01 Vorzugsaktien Class B2
Aktienkapital neu: CHF 518'497.64 [bisher: CHF 475'045.68]. Liberierung Aktienkapital neu: CHF 518'497.64 [bisher: CHF 475'045.68]. Aktien neu: 39'999'969 vinkulierte Namenaktien zu CHF 0.01, 9'180'309 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B1) und 2'669'486 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B2) [bisher: 39'999'969 vinkulierte Namenaktien zu CHF 0.01, 889'828 Namenaktien zu CHF 0.01 (Vorzugsaktien Class B2) und 6'614'771 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B1)]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗ SHAB HR02-1006724432 ↗Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability
Published by 9 Aug 2026